WA
SVA

WFG Advisors’s Sinovac Biotech, Ltd SVA Stock Holding History

WFG Advisors’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-200
Closed -$1K – 1778
2015
Q3 		$1K Hold
200
– – ﹤0.01% 1591
2015
Q2 		$1K Hold
200
– – ﹤0.01% 1649
2015
Q1 		$1K Hold
200
– – ﹤0.01% 1744
2014
Q4 		$1K Hold
200
– – ﹤0.01% 2065
2014
Q3 		$1K Hold
200
– – ﹤0.01% 2088
2014
Q2 		$1K Hold
200
– – ﹤0.01% 1974
2014
Q1 		$1K Hold
200
– – ﹤0.01% 1969
2013
Q4 		$1K Buy
+200
New +$1.21K ﹤0.01% 2208

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

WFG Advisors's SVA Position: Q4 2015 in Review

WFG Advisors sold out of Sinovac Biotech, Ltd (SVA) in Q4 2015, closing a stake of 200 shares — an estimated $1K sold.

WFG Advisors first reported a position in SVA in Q4 2013 and held it in 8 quarters. The position peaked at $1K in Q3 2015. 40 funds tracked by Wall St. Rank hold SVA as of Q4 2015.

  • WFG Advisors reported no remaining Sinovac Biotech, Ltd position as of Q4 2015 after selling out during the quarter.
  • WFG Advisors sold 200 Sinovac Biotech, Ltd shares in Q4 2015, an estimated $1K.
  • WFG Advisors first reported a position in Sinovac Biotech, Ltd in Q4 2013 and held it in 8 quarters.
  • WFG Advisors's Sinovac Biotech, Ltd position peaked at $1K in Q3 2015.
  • 40 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2015.

Based on WFG Advisors's 13F filing for Q4 2015, filed 9 Feb 2016.